Calibration signals were within expected ranges.Quality controls were within specified ranges.Samples from the patient were provided for investigation and the results obtained by the customer could be reproduced.Investigation of the sample performed with a competitor test determined the complained sample was clearly reactive for rubella igg.The sample did not contain any interfering factors.The patient is regarded as anti-rubella igg low positive.The complained sample is regarded as false negative, however, close to the cut-off of the assay (10 iu/ml).The rubella igg reagent performs within specification.Product labeling states: "a test result < 10 iu/ml does not completely rule out the possibility of an acute rubella infection.Specimens taken very early in the acute phase of infection may not contain any detectable amounts of rubella igg antibodies or may have an antibody concentration < 10 iu/ml." for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other finding.
|